MARKET OVERVIEW
The global cataract surgical devices market was valued at USD 9.2 billion in 2024 and is projected to reach USD 12.8 billion by 2033, growing at a CAGR of 3.48%. This surge is driven by the rising prevalence of cataracts, especially among the aging population, along with advancements in device technologies—such as femtosecond lasers and phacoemulsification systems expanding healthcare access and expenditure worldwide. 

STUDY ASSUMPTION YEARS

• BASE YEAR: 2024
• HISTORICAL YEAR: 2019–2024
• FORECAST YEAR: 2025–2033

Cataract Surgical Devices Market Key Takeaways

• Market reached USD 9.2 billion in 2024, projected to hit USD 12.8 billion by 2033, growing at 3.48% CAGR.
• North America dominates the market.
• Intraocular lenses (IOLs) hold the largest share among product types.
• Hospitals are the primary end-users, outperforming clinics and surgical centers.
• Technological innovations—like femtosecond lasers and advanced IOL materials—are enhancing surgical outcomes.
• Emerging markets across Asia Pacific, Latin America, and MEA show rapid growth due to improving healthcare infrastructure.

MARKET GROWTH FACTORS

1. How Does Aging Population Affect Cataract Surgery?
As people age, the need for cataract surgery is increasing rapidly, which brings both clinical and systemic hurdles. Older patients often face tougher cataract nuclei, smaller pupils, and more fragile eye tissues, making the surgery more complex and heightening the risk of complications like posterior capsule rupture, infections, corneal edema, and higher intraocular pressure. Although surgery usually enhances vision, the benefits can be less significant for older individuals due to limited visual improvements and the presence of other health issues like age-related macular degeneration. This growing demand for surgical care puts a lot of pressure on ophthalmologists and healthcare systems, and elderly patients can also be more difficult to manage during procedures. Additionally, the disparities in access to treatment, especially for those with limited insurance, underscore the urgent public health challenge of cataract management in aging populations.

2. How Do Lifestyle Diseases Like Diabetes and Hypertension Contribute to Cataract Surgeries?
Lifestyle diseases, including diabetes and hypertension, can really speed up the formation of cataracts by damaging the eye’s natural lens and causing early vision issues. For those with diabetes, high blood sugar can make the lens swell and lead to a buildup of sorbitol, which causes fluid retention, structural damage, and quicker clouding. This often results in Posterior Subcapsular or Cortical Cataracts. Hypertension makes things worse by reducing blood flow to the eye and harming blood vessels, which increases lens opacity. However, if you manage these conditions well—by keeping your blood sugar and blood pressure in check, eating a healthy diet, exercising, managing stress, and getting regular eye exams you can significantly delay the progression of cataracts and reduce the likelihood of needing surgery.

3. How Have Technological Advancements Improved Cataract Surgery?
The world of cataract surgery has been revolutionized by recent technological breakthroughs, turning it into a procedure that is not only highly precise but also minimally invasive and safer for patients. Innovations like femtosecond laser-assisted surgery (FLACS) allow for incredibly accurate incisions, lens fragmentation, and capsule openings. Meanwhile, advanced imaging tools such as Optical Coherence Tomography (OCT) provide real-time visuals that help in planning, even for the most complex cases. The use of artificial intelligence and robotic systems has further enhanced the consistency of results, reduced errors, and made surgical outcomes more predictable. Patients are now enjoying the benefits of premium intraocular lenses (IOLs), which include multifocal, toric, extended depth of focus (EDOF), and light-adjustable lenses (LALs). These lenses not only tackle astigmatism but also restore vision across different distances with remarkable precision.

Request for a sample copy of this report:

https://www.imarcgroup.com/cataract-surgical-devices-market/requestsample

MARKET SEGMENTATION

• By Product Type:
• Ophthalmic Viscoelastic Devices (OVDs)
• Intraocular Lenses (IOLs)
• Femtosecond Laser
• Phacoemulsification Equipment
• Others
• By End‑Use:
• Hospitals
• Eye Care Clinics
• Eye Treatment and Surgical Centres
• Breakup by Region:

                  • North America (United States, Canada)

                  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

                  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

                  • Latin America (Brazil, Mexico, Others)

                  • Middle East and Africa

REGIONAL INSIGHTS
North America is at the forefront of the global cataract surgical devices market, driven by high healthcare spending, a strong embrace of cutting-edge technologies like femtosecond lasers, and a growing elderly population. The region boasts a well-established surgical infrastructure and a solid reimbursement system, which further cements its leading position and consistent growth path.

RECENT DEVELOPMENTS & NEWS
The cataract field is buzzing with innovation: we're seeing an uptick in the use of femtosecond lasers and 3D imaging systems, along with robot-assisted surgeries that enhance precision. Manufacturers are also rolling out silicone-based intraocular lenses (IOLs) that promise better optics and less reliance on glasses. Around the world, governments are increasing funding for cataract care, making it easier for people to access these advanced treatments.

KEY PLAYERS

• Abbott Laboratories
• Hoya Corporation
• Carl Zeiss Meditec AG
• Alcon Laboratories Inc.
• Essilor International S.A.

Ask Analyst for Customization: 

https://www.imarcgroup.com/request?type=report&id=840&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us: 

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (+1-201971-6302)